[cnbc 3000099440]
The biotech sector is up more than 1 percent today, and discussing what investors can expect after tomorrow’s health care reform ruling, with ISI’s biotech and pharmaceuticals major analyst Mark Schoenebaum. “If tomorrow the whole bill is struck down, technically, earnings and revenue estimates for all of biotech and all of pharma companies are going to go up,” says Schoenebaum.
Melissa Lee anchors a fast-paced discussion among four professional Wall Street traders. An hour after the bell Fast Money hosts one of the best trading discussions of the day.
Video © and provided by CNBC.
Melissa Lee anchors a fast-paced discussion among four professional Wall Street traders. An hour after the bell
Be the first to comment